{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:10:45Z","timestamp":1769749845855,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00408-013-9481-5","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T06:18:41Z","timestamp":1369981121000},"page":"565-571","source":"Crossref","is-referenced-by-count":45,"title":["Mycobacterial Infections in Patients Treated with Tumor Necrosis Factor Antagonists in South Korea"],"prefix":"10.1007","volume":"191","author":[{"given":"Sang Kook","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song Yee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Ye","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moo Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"issue":"22","key":"9481_CR1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343(22):1594\u20131602","journal-title":"N Engl J Med"},{"issue":"7","key":"9481_CR2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","volume":"44","author":"A Keat","year":"2005","unstructured":"Keat A, Barkham N, Bhalla A, Gaffney K, Marzo-Ortega H, Paul S, Rogers F, Somerville M, Sturrock R, Wordsworth P (2005) BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Rheumatology (Oxford) 44(7):939\u2013947","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"9481_CR3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353(23):2462\u20132476","journal-title":"N Engl J Med"},{"issue":"5","key":"9481_CR4","first-page":"587","volume":"24","author":"NF Woolacott","year":"2006","unstructured":"Woolacott NF, Khadjesari ZC, Bruce IN, Riemsma RP (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review. Clin Exp Rheumatol 24(5):587\u2013593","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"9481_CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","volume":"8","author":"RS Wallis","year":"2008","unstructured":"Wallis RS (2008) Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 8(10):601\u2013611","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"9481_CR6","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","volume":"36","author":"I Solovic","year":"2010","unstructured":"Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Scholvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C (2010) The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 36(5):1185\u20131206","journal-title":"Eur Respir J"},{"issue":"9","key":"9481_CR7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38(9):1261\u20131265","journal-title":"Clin Infect Dis"},{"issue":"11","key":"9481_CR8","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/587989","volume":"46","author":"KL Winthrop","year":"2008","unstructured":"Winthrop KL, Yamashita S, Beekmann SE, Polgreen PM (2008) Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis 46(11):1738\u20131740","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9481_CR9","first-page":"706","volume":"34","author":"SS Seong","year":"2007","unstructured":"Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34(4):706\u2013711","journal-title":"J Rheumatol"},{"issue":"3","key":"9481_CR10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-010-1605-1","volume":"30","author":"S Mankia","year":"2011","unstructured":"Mankia S, Peters JE, Kang S, Moore S, Ehrenstein MR (2011) Tuberculosis and anti-TNF treatment: experience of a central London hospital. Clin Rheumatol 30(3):399\u2013401","journal-title":"Clin Rheumatol"},{"issue":"3","key":"9481_CR11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, Symmons DP (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69(3):522\u2013528","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"9481_CR12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.idc.2010.04.008","volume":"24","author":"B Taiwo","year":"2010","unstructured":"Taiwo B, Glassroth J (2010) Nontuberculous mycobacterial lung diseases. Infect Dis Clin North Am 24(3):769\u2013789","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"9481_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00408-010-9240-9","volume":"188","author":"EE McGrath","year":"2010","unstructured":"McGrath EE, Blades Z, McCabe J, Jarry H, Anderson PB (2010) Nontuberculous mycobacteria and the lung: from suspicion to treatment. Lung 188(4):269\u2013282","journal-title":"Lung"},{"issue":"3","key":"9481_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MCP.0b013e3283292679","volume":"15","author":"SM Arend","year":"2009","unstructured":"Arend SM, van Soolingen D, Ottenhoff TH (2009) Diagnosis and treatment of lung infection with nontuberculous mycobacteria. Curr Opin Pulm Med 15(3):201\u2013208","journal-title":"Curr Opin Pulm Med"},{"issue":"12","key":"9481_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ncprheum0949","volume":"4","author":"J Ingen van","year":"2008","unstructured":"van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D (2008) Mycobacterial disease in patients with rheumatic disease. Nat Clin Pract Rheumatol 4(12):649\u2013656","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"22","key":"9481_CR16","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"YA Kang","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293(22):2756\u20132761","journal-title":"JAMA"},{"issue":"6","key":"9481_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jcla.20278","volume":"22","author":"SW Ryoo","year":"2008","unstructured":"Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, Park YK, Kang S (2008) Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal 22(6):415\u2013420","journal-title":"J Clin Lab Anal"},{"issue":"10","key":"9481_CR18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/00365548.2012.681695","volume":"44","author":"SK Lee","year":"2012","unstructured":"Lee SK, Lee EJ, Kim SK, Chang J, Jeong SH, Kang YA (2012) Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand J Infect Dis 44(10):733\u2013738","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"9481_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K (2007) An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367\u2013416","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"9481_CR20","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ Gomez-Reino","year":"2003","unstructured":"Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122\u20132127","journal-title":"Arthritis Rheum"},{"issue":"15","key":"9481_CR21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098\u20131104","journal-title":"N Engl J Med"},{"issue":"1","key":"9481_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/187152809787582543","volume":"8","author":"A Mootoo","year":"2009","unstructured":"Mootoo A, Stylianou E, Arias MA, Reljic R (2009) TNF-alpha in tuberculosis: a cytokine with a split personality. Inflamm Allergy Drug Targets 8(1):53\u201362","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"1","key":"9481_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.jidsymp.5650027","volume":"12","author":"PL Lin","year":"2007","unstructured":"Lin PL, Plessner HL, Voitenok NN, Flynn JL (2007) Tumor necrosis factor and tuberculosis. J Investig Dermatol Symp Proc 12(1):22\u201325","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"9481_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","volume":"71","author":"DY Chen","year":"2012","unstructured":"Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL (2012) Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFalpha inhibitors: the utility of IFNgamma assay. Ann Rheum Dis 71(2):231\u2013237","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"9481_CR25","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3201\/eid1510.090310","volume":"15","author":"KL Winthrop","year":"2009","unstructured":"Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA (2009) Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 15(10):1556\u20131561","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"9481_CR26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10096-011-1329-4","volume":"31","author":"C Piersimoni","year":"2012","unstructured":"Piersimoni C (2012) Nontuberculous mycobacteria infection in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis 31(4):397\u2013403","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"9481_CR27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MAJ.0b013e31820f8c70","volume":"341","author":"MD Iseman","year":"2011","unstructured":"Iseman MD (2011) Mycobacterial infections in the era of modern biologic agents. Am J Med Sci 341(4):278\u2013280","journal-title":"Am J Med Sci"},{"issue":"9","key":"9481_CR28","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1128\/AAC.42.9.2336","volume":"42","author":"S Bala","year":"1998","unstructured":"Bala S, Hastings KL, Kazempour K, Inglis S, Dempsey WL (1998) Inhibition of tumor necrosis factor alpha alters resistance to Mycobacterium avium complex infection in mice. Antimicrob Agents Chemother 42(9):2336\u20132341","journal-title":"Antimicrob Agents Chemother"},{"issue":"8942","key":"9481_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0140-6736(95)90059-4","volume":"345","author":"M Levin","year":"1995","unstructured":"Levin M, Newport MJ, D\u2019Souza S, Kalabalikis P, Brown IN, Lenicker HM, Agius PV, Davies EG, Thrasher A, Klein N et al (1995) Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 345(8942):79\u201383","journal-title":"Lancet"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-013-9481-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9481-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T08:40:49Z","timestamp":1563093649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-013-9481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9481"],"URL":"https:\/\/doi.org\/10.1007\/s00408-013-9481-5","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]}}}